Financhill
Back

Akero Therapeutics Vs. Viking Therapeutics Industry Stock Comparison

Sell
38

AKRO
Akero Therapeutics

Last Price:
19.72
Seasonality Move:
16.15%
Buy
67

VKTX
Viking Therapeutics

Last Price:
74.28
Seasonality Move:
18.5%
Sell
38
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $19.74. The Score for AKRO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Viking Therapeutics (VKTX) is a Buy

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $74.31. The Score for VKTX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • VKTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $19.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $74.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.34 Sell
Relative Strength Index (14 RSI): 33.69 Sell
Chaikin Money Flow: 413429 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.72 - 24.08) Sell
Bollinger Bands (100): (20.12 - 26.06) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 58.75 Buy
Chaikin Money Flow: 3146467 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (65.96 - 77.78) Buy
Bollinger Bands (100): (18.89 - 70.61) Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.45 Sell
20-day SMA: 21.84 Sell
50-day SMA: 24.58 Sell
200-day SMA: 28.82 Sell
8-day EMA: 20.42 Sell
20-day EMA: 21.77 Sell
50-day EMA: 23.08 Sell
200-day EMA: 27.44 Sell

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.46 Buy
20-day SMA: 70.59 Buy
50-day SMA: 68.11 Buy
200-day SMA: 28.71 Buy
8-day EMA: 68.34 Buy
20-day EMA: 68.99 Buy
50-day EMA: 63.17 Buy
200-day EMA: 36.96 Buy

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.41 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):